Manel Cascalló

2.3k total citations
49 papers, 1.5k citations indexed

About

Manel Cascalló is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Manel Cascalló has authored 49 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Genetics, 34 papers in Oncology and 27 papers in Molecular Biology. Recurrent topics in Manel Cascalló's work include Virus-based gene therapy research (44 papers), CAR-T cell therapy research (25 papers) and Cancer Research and Treatments (17 papers). Manel Cascalló is often cited by papers focused on Virus-based gene therapy research (44 papers), CAR-T cell therapy research (25 papers) and Cancer Research and Treatments (17 papers). Manel Cascalló collaborates with scholars based in Spain, United States and United Kingdom. Manel Cascalló's co-authors include Ramón Alemany, Alena Gros, Juan J. Rojas, Sònia Guedan, Elena Mercadé, Marta Giménez-Alejandre, Jordi Martínez‐Quintanilla, Adela Mazo, Rafael Moreno and Marta M. Alonso and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Manel Cascalló

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manel Cascalló Spain 25 1.2k 906 865 311 188 49 1.5k
Gerd Bauerschmitz Germany 23 1.3k 1.0× 930 1.0× 1.0k 1.2× 287 0.9× 153 0.8× 55 1.6k
Tanja Hakkarainen Finland 23 949 0.8× 639 0.7× 847 1.0× 247 0.8× 115 0.6× 36 1.4k
DT Curiel United States 26 1.4k 1.2× 713 0.8× 1.5k 1.8× 218 0.7× 182 1.0× 51 2.1k
Kilian Guse Finland 22 781 0.6× 570 0.6× 717 0.8× 226 0.7× 99 0.5× 32 1.3k
Julia Davydova United States 22 833 0.7× 596 0.7× 663 0.8× 291 0.9× 110 0.6× 66 1.2k
D T Curiel United States 16 1.0k 0.8× 660 0.7× 1.0k 1.2× 171 0.5× 124 0.7× 21 1.5k
Juan J. Rojas Spain 17 731 0.6× 575 0.6× 455 0.5× 196 0.6× 113 0.6× 23 967
Siri Tähtinen Finland 20 837 0.7× 1.0k 1.1× 670 0.8× 226 0.7× 204 1.1× 32 1.6k
Barbara Leuchs Germany 22 1.1k 0.9× 470 0.5× 942 1.1× 111 0.4× 343 1.8× 51 1.8k
Elizabeth J. Ilett United Kingdom 24 1.2k 1.0× 1.2k 1.3× 541 0.6× 307 1.0× 397 2.1× 38 1.9k

Countries citing papers authored by Manel Cascalló

Since Specialization
Citations

This map shows the geographic impact of Manel Cascalló's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manel Cascalló with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manel Cascalló more than expected).

Fields of papers citing papers by Manel Cascalló

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manel Cascalló. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manel Cascalló. The network helps show where Manel Cascalló may publish in the future.

Co-authorship network of co-authors of Manel Cascalló

This figure shows the co-authorship network connecting the top 25 collaborators of Manel Cascalló. A scholar is included among the top collaborators of Manel Cascalló based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manel Cascalló. Manel Cascalló is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐Carbonero, Rocio, Roberto Pazo-Cid, Teresa Macarulla, et al.. (2024). VIRAGE: A phase IIb, open-label, randomized study of nab-paclitaxel and gemcitabine plus/minus VCN-01 in patients with metastatic pancreatic cancer.. Journal of Clinical Oncology. 42(16_suppl). TPS4210–TPS4210. 1 indexed citations
2.
García, Margarita, Rafael Moreno, Marta Gil-Martín, et al.. (2018). A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients. Human Gene Therapy. 30(3). 352–364. 80 indexed citations
3.
García, Margarita, Rafael Moreno, Marta Gil, et al.. (2018). A phase I trial of oncolytic adenovirus ICOVIR-5 administered intravenously to melanoma patients. 2 indexed citations
4.
Martínez-Vélez, Naiara, Enric Xipell, Arlet Acanda de la Rocha, et al.. (2015). The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma. Clinical Cancer Research. 22(9). 2217–2225. 36 indexed citations
5.
Rodríguez-García, Alba, Marta Giménez-Alejandre, Juan J. Rojas, et al.. (2014). Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression. Clinical Cancer Research. 21(6). 1406–1418. 87 indexed citations
6.
Puig-Saus, Cristina, Alba Rodríguez-García, Rafael Moreno, et al.. (2014). A pRb-responsive, RGD-modified, and Hyaluronidase-armed Canine Oncolytic Adenovirus for Application in Veterinary Oncology. Molecular Therapy. 22(5). 986–998. 40 indexed citations
7.
Puig-Saus, Cristina, et al.. (2013). Adeno-Associated Virus Enhances Wild-Type and Oncolytic Adenovirus Spread. Human Gene Therapy Methods. 24(6). 372–380. 4 indexed citations
8.
Gros, Alena, Cristina Puig-Saus, Sònia Guedan, et al.. (2010). Verapamil Enhances the Antitumoral Efficacy of Oncolytic Adenoviruses. Molecular Therapy. 18(5). 903–911. 16 indexed citations
9.
Rojas, Juan J., Sònia Guedan, Peter F. Searle, et al.. (2010). Minimal RB-responsive E1A Promoter Modification to Attain Potency, Selectivity, and Transgene-arming Capacity in Oncolytic Adenoviruses. Molecular Therapy. 18(11). 1960–1971. 61 indexed citations
10.
Alcayaga‐Miranda, Francisca, Manel Cascalló, Juan J. Rojas, Josep Pastor, & Ramón Alemany. (2010). Osteosarcoma cells as carriers to allow antitumor activity of canine oncolytic adenovirus in the presence of neutralizing antibodies. Cancer Gene Therapy. 17(11). 792–802. 19 indexed citations
11.
Guedan, Sònia, Juan J. Rojas, Alena Gros, et al.. (2010). Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth. Molecular Therapy. 18(7). 1275–1283. 171 indexed citations
12.
Martínez‐Quintanilla, Jordi, Manel Cascalló, Cristina Fillat, & Ramón Alemany. (2009). Antitumor Therapy Based on Cellular Competition. Human Gene Therapy. 20(7). 728–738. 5 indexed citations
13.
Matskevich, Alexey A., et al.. (2009). Vero Cells as a Model to Study the Effects of Adenoviral Gene Delivery Vectors on the RNAi System in Context of Viral Infection. Journal of Innate Immunity. 1(4). 389–394. 15 indexed citations
14.
Gros, Alena, Jordi Martínez‐Quintanilla, Cristina Puig-Saus, et al.. (2008). Bioselection of a Gain of Function Mutation that Enhances Adenovirus 5 Release and Improves Its Antitumoral Potency. Cancer Research. 68(21). 8928–8937. 50 indexed citations
15.
Cascalló, Manel, et al.. (2006). Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting. Journal of General Virology. 87(9). 2487–2495. 65 indexed citations
16.
17.
Cascalló, Manel, Joaquim Calbó, Gabriel Capellá, et al.. (2005). Enhancement of Gemcitabine-Induced Apoptosis by Restoration of p53 Function in Human Pancreatic Tumors. Oncology. 68(2-3). 179–189. 16 indexed citations
18.
Peñuelas, Silvia, Manel Cascalló, José Luís Hernández, et al.. (2004). Expression Profiles of a Human Pancreatic Cancer Cell Line upon Induction of Apoptosis Search for Modulators in Cancer Therapy. Oncology. 67(3-4). 277–290. 10 indexed citations
19.
Cascalló, Manel & Ramón Alemany. (2004). Adenovirus-Mediated Gene Transfer to Tumor Cells. Humana Press eBooks. 246. 121–138. 6 indexed citations
20.
Mercadé, Elena, Manel Cascalló, Meritxell Carrió, et al.. (2001). Treatment based on a combination of the CYP2B1/cyclophosphamide system and p53 delivery enhances tumour regression in human pancreatic cancer.. Annals of Oncology. 12(3). 379–388. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerd Bauerschmitz Breakdown of academic impact, for papers by Tanja Hakkarainen Breakdown of academic impact, for papers by DT Curiel Breakdown of academic impact, for papers by Kilian Guse Breakdown of academic impact, for papers by Julia Davydova Breakdown of academic impact, for papers by D T Curiel Breakdown of academic impact, for papers by Juan J. Rojas Breakdown of academic impact, for papers by Siri Tähtinen Breakdown of academic impact, for papers by Barbara Leuchs Breakdown of academic impact, for papers by Elizabeth J. Ilett
Rankless by CCL
2026